ovarian carcinomas
Original Article Expression of TC1 (C8orf4), Atonal homolog 1 and β-catenin is associated with the malignant progression of ovarian carcinomas
... of ovarian carcinomas using ...in ovarian carcinomas, ...cell carcinomas (100%, 8/8) was much more than that in Mucinous adenocarcinomas ...of ovarian carcinomas ...
7
Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian carcinomas with platinum resistance.
... Although ovarian carcinomas with mutated BRCA1 or BRCA2 are sensitive to platinum compounds, such carcinomas eventually develop platinum ...BRCA1-mutated ovarian cancer with platinum ...
26
Original Article PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis
... Epithelial ovarian cancer is the most common tumor of ...in ovarian epithelial ...epithelial ovarian tumors, and its relationship with clinical pathological ...epithelial ovarian tumor ...
9
Pathobiology of ovarian carcinomas
... LGSC is less common, representing 10% 15% of serous carcinomas and < 5% of all ovarian carcinomas. This carcinoma is associated with a serous borderline tumor or represents the recurrent lesion ...
6
Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas
... coamplify in leukemias. To examine the relationship of gene amplification to the expression of these genes in tumors, ACHE and CHE genes and their expression were studied in primary ovarian carcinomas. DNA ...
10
Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome
... genetic ovarian carcinomas prog- nostic pattern contains 1073 difference expression genes involved in the 4 dominant network modules successfully divided a dataset with random OCA cases (n = 80) into 3 ...
10
Differential expression of alpha 2 macroglobulin in response to dietylstilbestrol and in ovarian carcinomas in chickens
... chicken ovarian cancers [38]. In three hens, ovarian tumor cells were classified as Stage III as they had metastasized to the gastrointestinal tract and superficial surface of the liver with profuse ascites ...
10
P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
... in ovarian carcinomas has been demonstrated in several studies, but the results of these studies are difficult to compare because the methodology and criteria for evaluation varied greatly ...of ...
9
Original Article The prognostic significance of pdl1 and foxp3 expressions in tumor cells and the tumor microenvironment of ovarian epithelial tumors
... sion have been reported in patients with gastric cancer, colorectal carcinoma and breast can- cer [13, 14]. In addition, varying proportions of PD-L1 expressions and their prognostic values in ovarian ...
7
Key words
... of ovarian tumors [2, ...differentiated ovarian carcinomas in the cur- rent ...in ovarian cancer ...in ovarian carcino- mas is in line with other studies [1, 6, ...of ovarian ...
8
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment
... Significant clinical, pathologic, and pathogenesis differences have been described between LGSOC and HGSOC, although most research on the diversity of these two cancers has been focused on the impact of cancer cell ...
11
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs
... Forty-four ovarian carcinomas were collected from patients who underwent surgical resection at the Department of Gynecology of the First Affiliated Hospital of China Medi- cal University (Shenyang, ...
11
Ovarian surface epithelium: family history and early events in ovarian cancer
... of ovarian carcinomas and normal human OSE cells using high- throughput genomic and proteomic technologies ...in ovarian carcinogenesis by comparing gene expression patterns in ovarian cancers ...
8
Serum Calprotectin and Prealbumin Levels among Ovarian Cancer Patients Aged 30 45 Years
... with ovarian carcinomas, borderline ovarian tumours (BOT), and be- nign ovarian tumours ...in ovarian carcinoma, compared with controls, as well as with BOT, but remarked that its ...
10
Editorial Commentary Fallopian tube as main source for ovarian and pelvic (non- endometrial) serous carcinomas
... rous carcinomas to the fallopian tube is simply observational: in risk-reducing salpingo- oophorectomy specimens performed on women at increased risk for the development of ovarian carcinomas, ...
5
Original Article Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas
... in ovarian carcinomas, but the exact percentage of HER2 positive tumors is varied in the literature ...of ovarian serous car- cinoma by ...in ovarian serous car- cinoma is lower than that ...
8
PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy
... in ovarian tumors and is characteristic for the epithelial phenotypes (serous, clear cell, and endometrioid) ...an ovarian metastatic carcinoma that could derive from a primary tumor in pancreas, colon or ...
7
miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
... To overcome the limitations in current researches, we integrated these results by performing a meta-analysis applying the recently published robust rank aggregation (RRA) method [7], followed by pathway analysis, to ...
13
Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
... benign ovarian tumors and low-grade malignant tumors without ...in ovarian papillary ser- ous carcinomas than in ovarian serous ...in ovarian cancer was higher as the clinical stage ...
8
BRCA Mutation: A Review of Breast Cancer
... Women with high-risk BRCA2 mutations, with screening but with no prophylactic medical or surgical intervention, would have only seventy one percentage chance to reach age 70, thirteen percentage points lower than normal. ...
9